Financial statements Biogeneza
Balance sheet of Biogeneza
Company age:
Age:
22 y. 3 m. 15 d.
Share capital:
Share capital:
45 000 PLN
Balance sheet data of BIOGENEZA
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Total assets | 1 301 384,63 | 1 156 629,14 | 1 055 526,70 |
| A. Fixed assets | 573 324,89 | 564 498,41 | 555 671,93 |
| B. Current assets | 728 059,74 | 592 130,73 | 499 854,77 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 |
| Total liabilities | 1 301 384,63 | 1 156 629,14 | 1 055 526,70 |
| A. Equity | 1 279 370,83 | 1 140 245,01 | 1 022 905,91 |
| B. Liabilities and provisions for liabilities | 22 013,80 | 16 384,13 | 32 620,79 |
| I. Long-term liabilities | 1 750,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 19 673,32 | 10 350,05 | 25 963,77 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.